CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-23 | HENDERSON REBECCA M Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −3,046 | 0 | ||
| 2021-02-23 | AYERS JONATHAN W Director | Exercise or conversion | +1,476 | $67.85 | $100K | 654,213 |
| 2021-02-23 | AYERS JONATHAN W Director | Exercise or conversion · Incentive Stock Option (right-to-buy) | −1,476 | 0 | ||
| 2021-02-22 | Underberg Sharon E. SVP, Gen. Counsel & Secretary | Exercise or conversion | +483 | $206.94 | $100K | 1,878 |
| 2021-02-22 | Underberg Sharon E. SVP, Gen. Counsel & Secretary | Exercise or conversion · Incentive Stock Option (right-to-buy) | −483 | 1,449 | ||
| 2021-02-22 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion | +1,475 | $67.85 | $100K | 55,697 |
| 2021-02-22 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion · Incentive Stock Option (right-to-buy) | −1,475 | 0 | ||
| 2021-02-22 | JUNIUS DANIEL M Director | Exercise or conversion | +898 | $79.54 | $71K | 3,773 |
| 2021-02-22 | JUNIUS DANIEL M Director | Exercise or conversion | +1,000 | $85.00 | $85K | 4,773 |
| 2021-02-22 | JUNIUS DANIEL M Director | Sale | −10 | $539.19 | $5K | 4,763 |
| 2021-02-22 | JUNIUS DANIEL M Director | Sale | −1,888 | $538.57 | $1.0M | 2,875 |
| 2021-02-22 | JUNIUS DANIEL M Director | Exercise or conversion · Incentive Stock Option (right-to-buy) | −898 | 0 | ||
| 2021-02-22 | JUNIUS DANIEL M Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −1,000 | 4,902 | ||
| 2021-02-18 | AYERS JONATHAN W Director | Exercise or conversion | +1,000 | $79.54 | $80K | 653,737 |
| 2021-02-18 | AYERS JONATHAN W Director | Sale | −1,000 | $555.56 | $556K | 652,737 |
| 2021-02-18 | AYERS JONATHAN W Director | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | +1,000 | 147,632 | ||
| 2021-02-18 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +1,474 | $67.85 | $100K | 26,188 |
| 2021-02-18 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion · Incentive Stock Option (right-to-buy) | −1,474 | 0 | ||
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Exercise or conversion | +25,000 | $52.00 | $1.3M | 68,090 |
| 2021-02-17 | MAZELSKY JONATHAN JAY President & CEO | Sale | −3,940 | $535.94 | $2.1M | 64,150 |
Page 73 of 74 · 1,474 trades